Mesenchymal Stem Cells and Cardiovascular Disease: A Bench to Bedside Roadmap
Joint Authors
Mazo, Manuel
Araña, Miriam
Pelacho, Beatriz
Prósper, Felipe
Source
Issue
Vol. 2012, Issue 2012 (31 Dec. 2012), pp.1-11, 11 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2011-10-24
Country of Publication
Egypt
No. of Pages
11
Abstract EN
In recent years, the incredible boost in stem cell research has kindled the expectations of both patients and physicians.
Mesenchymal progenitors, owing to their availability, ease of manipulation, and therapeutic potential, have become one of the most attractive options for the treatment of a wide range of diseases, from cartilage defects to cardiac disorders.
Moreover, their immunomodulatory capacity has opened up their allogenic use, consequently broadening the possibilities for their application.
In this review, we will focus on their use in the therapy of myocardial infarction, looking at their characteristics, in vitro and in vivo mechanisms of action, as well as clinical trials.
American Psychological Association (APA)
Mazo, Manuel& Araña, Miriam& Pelacho, Beatriz& Prósper, Felipe. 2011. Mesenchymal Stem Cells and Cardiovascular Disease: A Bench to Bedside Roadmap. Stem Cells International،Vol. 2012, no. 2012, pp.1-11.
https://search.emarefa.net/detail/BIM-1030001
Modern Language Association (MLA)
Mazo, Manuel…[et al.]. Mesenchymal Stem Cells and Cardiovascular Disease: A Bench to Bedside Roadmap. Stem Cells International No. 2012 (2012), pp.1-11.
https://search.emarefa.net/detail/BIM-1030001
American Medical Association (AMA)
Mazo, Manuel& Araña, Miriam& Pelacho, Beatriz& Prósper, Felipe. Mesenchymal Stem Cells and Cardiovascular Disease: A Bench to Bedside Roadmap. Stem Cells International. 2011. Vol. 2012, no. 2012, pp.1-11.
https://search.emarefa.net/detail/BIM-1030001
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1030001